Work

Abstract B005: An immunohistochemical PD-L1 companion diagnostic assay for treatment with durvalumab (MEDI4736) in NSCLC patients

Year: 2016

Type: conference-abstract

Source: Cancer Immunology Research

DOI: 10.1158/2326-6074.cricimteatiaacr15-b005

Authors: Marlon C. Rebelatto, Amita Mistry, Constantine Sabalos, Nicole Schechter, Jill Walker, Anita Midha, Keith E. Steele, Paul B. Robbins, Xia Li, Li Shi, John A. Blake-Haskins, Ramy A. Ibrahim, Laura Richman

Institutions: AstraZeneca (United Kingdom), AstraZeneca (United States)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2343387764

Cites:

Cited by: 2

Related to: 10